Zimmer Biomet Holdings (ZBH) return on equity (ROE)

Return on equity · fiscal 2025
5.6%

Zimmer Biomet Holdings (ZBH) earned a return on equity of 5.6% in fiscal 2025 (the year ended December 31, 2025). That is 1.7 percentage points lower than the 7.2% of fiscal 2024. Figures as of 17 Nov 2026, 23:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
5.6%
Change on fiscal 2024
−1.7 pts
Highest on record
15.5%fiscal 2017
Lowest on record
-3.4%fiscal 2018
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Zimmer Biomet Holdings return on equity (ROE), in more detail

Across the 19 fiscal years on record (2007–2025), the highest was 15.5% in fiscal 2017 and the lowest -3.4% in fiscal 2018. The fiscal 2025 figure is higher than in 33% of the 18 earlier fiscal years on record, whose median is 9.7%.

History · 19 fiscal years

Return on equity by fiscal year

Zimmer Biomet Holdings return on equity (ROE), year by year

Zimmer Biomet Holdings (ZBH) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
20255.6% 1.7 pts down
20247.2% 1.0 pts down
20238.2% 6.3 pts up
20221.9% 1.2 pts down
20213.2% 4.3 pts up
2020-1.1% 10.3 pts down
20199.1% 12.5 pts up
2018-3.4% 18.8 pts down
201715.5% 12.3 pts up
20163.2% 1.7 pts up
20151.5% 9.5 pts down
201411.0% 1.4 pts down
201312.4% 0.5 pts down
201212.9% 0.9 pts down
201113.8% 3.5 pts up
201010.3% 2.4 pts down
200912.7% 2.3 pts down
200815.0% 0.8 pts up
200714.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Zimmer Biomet Holdings and comparable companies
CompanyReturn on equityFiscal year
Tenet Healthcare THC33.3%2025
BioNTech BNTX-5.9%2025
Guardant Health GH-302.1%2023
Alnylam Pharmaceuticals ALNY39.8%2025
Zimmer Biomet Holdings ZBH5.6%2025
Medpace Holdings MEDP98.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ZBH

Zimmer Biomet Holdings, figure by figure

Zimmer Biomet Holdings (ZBH) overview: price, valuation and scorecardAll health care companies by market value

Zimmer Biomet Holdings return on equity (ROE): questions and answers

What is Zimmer Biomet Holdings's return on equity?

Zimmer Biomet Holdings (ZBH) earned a return on equity of 5.6% in fiscal 2025 (the year ended December 31, 2025). That is 1.7 percentage points lower than the 7.2% of fiscal 2024.

Is Zimmer Biomet Holdings's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 33% of the 18 earlier fiscal years on record, whose median is 9.7%.

What are the highest and lowest return on equity figures on record for Zimmer Biomet Holdings?

Across the 19 fiscal years on record (2007–2025), the highest was 15.5% in fiscal 2017 and the lowest -3.4% in fiscal 2018.

How is Zimmer Biomet Holdings's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Zimmer Biomet Holdings (ZBH) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ZBH/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.